Published in Clin Exp Immunol on January 01, 1997
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest (1998) 1.40
Porcine reproductive and respiratory syndrome virus infects mature porcine dendritic cells and up-regulates interleukin-10 production. Clin Vaccine Immunol (2008) 1.06
Identification of genes responsive to solar simulated UV radiation in human monocyte-derived dendritic cells. PLoS One (2009) 0.83
Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells. Hum Vaccin Immunother (2013) 0.81
Repeated doses of UVR cause minor alteration in cytokine serum levels in humans. Mediators Inflamm (2005) 0.78
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
Interleukin-10. Annu Rev Immunol (1993) 10.14
Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med (2001) 7.46
Reciprocal control of T helper cell and dendritic cell differentiation. Science (1999) 7.28
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A (1993) 4.45
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev (1997) 4.24
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol (1990) 3.77
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science (1990) 3.70
Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity (1999) 3.69
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Mouse models of tumor development in neurofibromatosis type 1. Science (1999) 3.40
Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol (1998) 3.38
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol (2001) 3.13
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1997) 2.95
Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol (2001) 2.85
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (1993) 2.63
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci U S A (1993) 2.58
Biological properties of interleukin 10. J Clin Immunol (1992) 2.50
Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol (1996) 2.42
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol (1998) 2.30
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology (2007) 2.23
Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol (2001) 2.20
Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol (1990) 2.04
Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices. Br J Surg (2011) 2.04
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol (1999) 2.03
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity (1997) 1.97
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol (1993) 1.92
Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur J Immunol (1993) 1.90
Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today (1991) 1.89
Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns (2013) 1.89
Expression cloning and characterization of a human IL-10 receptor. J Immunol (1994) 1.89
Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77
Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone (2001) 1.76
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol (1999) 1.73
Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A (1995) 1.71
Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol (2010) 1.68
Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol (1995) 1.68
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol (2001) 1.65
Stage-specific expression and genomic organization of the actin genes of the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.64
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis (1997) 1.63
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med (1994) 1.63
Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol (1990) 1.62
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol (1993) 1.62
IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol (1998) 1.62
Human atopen-specific types 1 and 2 T helper cell clones. J Immunol (1991) 1.62
Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol (1990) 1.59
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Crystal structure of Escherichia coli methionyl-tRNA synthetase highlights species-specific features. J Mol Biol (1999) 1.57
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med (2000) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol (2007) 1.55
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology (1999) 1.54
Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol (2004) 1.53
Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med (2001) 1.52
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
Properties of Clarke's column neurones. Acta Physiol Scand (1969) 1.50
[Heights and weights of Danish children]. Ugeskr Laeger (1982) 1.50
Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol (2000) 1.47
Altered brain activation to colorectal distention in visceral hypersensitive maternal-separated rats. Neurogastroenterol Motil (2012) 1.47
IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol (2001) 1.46
A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol (1997) 1.46
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol (1997) 1.46
Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res (1983) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain (1998) 1.41
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
[Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant]. Ned Tijdschr Geneeskd (2006) 1.39
Activation of complement in psoriasis. Clin Exp Dermatol (1998) 1.39
Neopterin, immune activation, and psoriasis. Lancet (1991) 1.38
[Imaging of non-traumatic and non-tumoral cord lesions]. J Radiol (2010) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35